These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I. Burgess W; Liu Q; Zhou J; Tang Q; Ozawa A; VanHoy R; Arkins S; Dantzer R; Kelley KW Neuroimmunomodulation; 1999; 6(1-2):56-68. PubMed ID: 9876236 [TBL] [Abstract][Full Text] [Related]
4. Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging. Kelley KW; Meier WA; Minshall C; Schacher DH; Liu Q; VanHoy R; Burgess W; Dantzer R Ann N Y Acad Sci; 1998 May; 840():518-24. PubMed ID: 9629278 [TBL] [Abstract][Full Text] [Related]
5. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Muench MO; Schneider JG; Moore MA Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685 [TBL] [Abstract][Full Text] [Related]
6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
7. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. French RA; Broussard SR; Meier WA; Minshall C; Arkins S; Zachary JF; Dantzer R; Kelley KW Endocrinology; 2002 Feb; 143(2):690-9. PubMed ID: 11796526 [TBL] [Abstract][Full Text] [Related]
8. The haematopoietic effects of growth hormone and insulin-like growth factor-I. Merchav S J Pediatr Endocrinol Metab; 1998; 11(6):677-85. PubMed ID: 9829220 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone-induced stimulation of multilineage human hematopoiesis. Hanley MB; Napolitano LA; McCune JM Stem Cells; 2005 Sep; 23(8):1170-9. PubMed ID: 15955828 [TBL] [Abstract][Full Text] [Related]
10. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow. Gazzola MV; Collins NH; Tafuri A; Keever CA Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965 [TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis. Schwartz GN; Warren MK; Sakano K; Szabo JM; Kessler SW; Pashapour A; Gress RE; Perdue JF Stem Cells; 1996 May; 14(3):337-50. PubMed ID: 8724700 [TBL] [Abstract][Full Text] [Related]
13. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. Merchav S; Tatarsky I; Hochberg Z J Clin Invest; 1988 Mar; 81(3):791-7. PubMed ID: 2963830 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [TBL] [Abstract][Full Text] [Related]
17. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580 [TBL] [Abstract][Full Text] [Related]
18. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow. Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652 [TBL] [Abstract][Full Text] [Related]
19. Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis. Welniak LA; Karas M; Yakar S; Anver MR; Murphy WJ; LeRoith D Biol Blood Marrow Transplant; 2004 Jan; 10(1):32-9. PubMed ID: 14752777 [TBL] [Abstract][Full Text] [Related]
20. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. Minshall C; Arkins S; Straza J; Conners J; Dantzer R; Freund GG; Kelley KW J Immunol; 1997 Aug; 159(3):1225-32. PubMed ID: 9233617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]